Neosonics is a first-in-class medical device to non-invasively screen and monitor infant meningitis. Neosonics uses high-resolution ultrasound, unique coupling materials and artificial intelligence to automatically count at the push of a button and in just a few seconds white blood cells (WBC) in the cerebrospinal fluid (CSF) directly below the infant fontanel, a well-established marker of infant meningitis screening and treatment monitoring.
Meningitis detection is challenging due to the unspecific signs associated to the infection, especially among youngest infants and newborns. Quick, easy and cost-effective, Neosonics will allow to confirm accurate suspicion of meningitis and to provide accurate diagnosis and treatment at a lower cost.
This is an investigational device. It is not for sale. The claims made on this website have not been evaluated by the FDA or the CE Mark authorities.